EGF MODULATION OF THE RAS-RELATED RHOB GENE-EXPRESSION IN HUMAN BREAST-CANCER CELL-LINES

被引:43
作者
DECREMOUX, P
GAUVILLE, C
CLOSSON, V
LINARES, G
CALVO, F
TAVITIAN, A
OLOFSSON, B
机构
[1] FAC MED LARIBOISIERE, UFR MED, INSERM, U248, F-75010 PARIS, FRANCE
[2] FAC MED LARIBOISIERE, UFR MED, PHARMACOL EXPTL LAB, PARIS, FRANCE
关键词
D O I
10.1002/ijc.2910590320
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The mRNA levels of the ras-related human rhoA, rhoB and rhoC genes were studied in human breast-cancer cell lines (HBCal), and in normal and immortalized mammary epithelial cells (HMEC) by Northern blot analysis and in situ hybridization. In contrast to the ubiquitous rhoA and rhoC gene expression, dramatic variations in the mRNA level of the rhoB gene were evidenced. The rhoB mRNA level appeared to be inversely correlated to the amounts of the epidermal-growth-factor(EGF) receptors in these cells. The rhoB transcripts were detected at high levels in ZR75-1, MCF7, HSL 53, HSL 59, HSL 90, T47D and SKBR3 HBCal, at hardly detectable levels in BT 20, MDA-MB 231 and H466B HBCal and at intermediate levels in normal and immortalized breast epithelial cells. Rapid and transient induction of the rhoB transcription was observed after EGF treatment in serum-deprived MDA-MB231, T47D and immortalized epithelial cells. In contrast, no modulation of rhoB expression by EGF could be objectified in the MCF7 and ZR75-1 cell lines. Yet a normal function of EGF receptors was evidenced, since the immediate early gene c-fos was rapidly induced, suggesting a constitutive expression of rhoB in these cell lines bypassing the regulation by EGF. In human mammary epithelial cells, rhoB mRNA is rapidly and transiently induced with EGF concentrations known to stimulate cell proliferation. This suggests that the rhoB product might be involved in a cascade that initiates or promotes cell proliferation, and plays an important role in EGF-stimulated growth of breast normal and cancer cells. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:408 / 415
页数:8
相关论文
共 35 条
  • [11] CULINE S, 1993, LEUKEMIA, V7, P601
  • [12] EPITHELIAL HBL-100 CELL-LINE DERIVED FROM MILK OF AN APPARENTLY HEALTHY WOMAN HARBORS SV40 GENETIC INFORMATION
    DEFROMENTEL, CC
    NARDEUX, PC
    SOUSSI, T
    LAVIALLE, C
    ESTRADE, S
    CARLONI, G
    CHANDRASEKARAN, K
    CASSINGENA, R
    [J]. EXPERIMENTAL CELL RESEARCH, 1985, 160 (01) : 83 - 94
  • [13] DONG XF, 1991, ANTICANCER RES, V11, P737
  • [14] ENGEL LW, 1978, CANCER RES, V38, P4327
  • [15] FITZPATRICK SL, 1984, CANCER RES, V44, P3442
  • [16] HORI Y, 1991, ONCOGENE, V6, P515
  • [17] JAHNER D, 1991, MOL CELL BIOL, V11, P3682
  • [18] THE CLINICAL-SIGNIFICANCE OF EPIDERMAL GROWTH-FACTOR RECEPTOR (EGF-R) IN HUMAN BREAST-CANCER - A REVIEW ON 5232 PATIENTS
    KLIJN, JGM
    BERNS, PMJJ
    SCHMITZ, PIM
    FOEKENS, JA
    [J]. ENDOCRINE REVIEWS, 1992, 13 (01) : 3 - 17
  • [19] DIFFERENTIAL REACTIVITY OF A NOVEL MONOCLONAL-ANTIBODY (DF3) WITH HUMAN-MALIGNANT VERSUS BENIGN BREAST-TUMORS
    KUFE, D
    INGHIRAMI, G
    ABE, M
    HAYES, D
    JUSTIWHEELER, H
    SCHLOM, J
    [J]. HYBRIDOMA, 1984, 3 (03): : 223 - 232
  • [20] LANCASTER CA, 1994, J BIOL CHEM, V269, P1137